Science that gotto market.

Context, A genomics platform had cleared regulatory review with no commercial motion behind it. Strong science, no route to clinical and research buyers across three regions.

What we did, Positioning and claims built with the science team, a launch narrative that stayed FDA- and EMA-safe, and a full campaign and enablement package shipped region by region.

Outcome, 0 to 200 B2B customers in two years across three regions.

Context, A Series A team had outgrown its original story: the product had moved on, the market framing hadn't, and the company narrative had to hold up in far more serious rooms.

What we did, Repositioned the company, rebuilt the narrative and the press motion around it, and ran the customer communication through a period of intense change.

Outcome, Repositioning and PR ahead of an acquisition, with 95% client retention held throughout.

Context, Climate data with real buyers behind it, but field marketing ran on instinct. No tracking, no attribution, no view of which markets were worth expanding into.

What we did, Rebuilt field marketing into a tracked pipeline engine: instrumented the funnel, tightened the proof-led narrative, and staged entry into new country markets.

Outcome, +25% YoY pipeline growth and five new country markets opened.